SG11202109423TA - Systems, compositions, and methods for target entity detection - Google Patents
Systems, compositions, and methods for target entity detectionInfo
- Publication number
- SG11202109423TA SG11202109423TA SG11202109423TA SG11202109423TA SG11202109423TA SG 11202109423T A SG11202109423T A SG 11202109423TA SG 11202109423T A SG11202109423T A SG 11202109423TA SG 11202109423T A SG11202109423T A SG 11202109423TA SG 11202109423T A SG11202109423T A SG 11202109423TA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- systems
- methods
- target entity
- entity detection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6862—Ligase chain reaction [LCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2521/00—Reaction characterised by the enzymatic activity
- C12Q2521/50—Other enzymatic activities
- C12Q2521/501—Ligase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2545/00—Reactions characterised by their quantitative nature
- C12Q2545/10—Reactions characterised by their quantitative nature the purpose being quantitative analysis
- C12Q2545/101—Reactions characterised by their quantitative nature the purpose being quantitative analysis with an internal standard/control
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962812878P | 2019-03-01 | 2019-03-01 | |
US202062962722P | 2020-01-17 | 2020-01-17 | |
PCT/US2020/020529 WO2020180741A1 (en) | 2019-03-01 | 2020-02-28 | Systems, compositions, and methods for target entity detection |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202109423TA true SG11202109423TA (en) | 2021-09-29 |
Family
ID=72338354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202109423TA SG11202109423TA (en) | 2019-03-01 | 2020-02-28 | Systems, compositions, and methods for target entity detection |
Country Status (9)
Country | Link |
---|---|
US (3) | US11085089B2 (de) |
EP (2) | EP3998349A3 (de) |
JP (1) | JP7344973B2 (de) |
KR (1) | KR102599718B1 (de) |
CN (1) | CN113748217B (de) |
AU (2) | AU2020233286B2 (de) |
CA (1) | CA3129868A1 (de) |
SG (1) | SG11202109423TA (de) |
WO (1) | WO2020180741A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113748217B (zh) | 2019-03-01 | 2023-08-25 | 仁慈生物分析公司 | 用于靶实体检测的系统、组合物和方法 |
EP4301782A1 (de) | 2021-03-05 | 2024-01-10 | Go Therapeutics, Inc. | Anti-glyco-cd44-antikörper und deren verwendungen |
WO2023004081A1 (en) * | 2021-07-21 | 2023-01-26 | Mercy Bioanalytics, Inc. | Compositions and methods for detection of esophageal cancer |
CA3227119A1 (en) * | 2021-07-21 | 2023-01-26 | Mercy Bioanalytics, Inc. | Compositions and methods for detection of breast cancer |
EP4374173A2 (de) * | 2021-07-21 | 2024-05-29 | Mercy Bioanalytics, Inc. | Zusammensetzungen und verfahren zur krebserkennung |
WO2023004083A2 (en) * | 2021-07-21 | 2023-01-26 | Mercy Bioanalytics, Inc. | Compositions and methods for detection of bile duct cancer |
WO2023004079A2 (en) * | 2021-07-21 | 2023-01-26 | Mercy Bioanalytics, Inc. | Compositions and methods for detection of liver cancer |
WO2023004082A1 (en) * | 2021-07-21 | 2023-01-26 | Mercy Bioanalytics, Inc. | Compositions and methods for detection of prostate cancer |
WO2023004077A2 (en) * | 2021-07-21 | 2023-01-26 | Mercy Bioanalytics, Inc. | Compositions and methods for detection of colorectal cancer |
WO2023004080A2 (en) * | 2021-07-21 | 2023-01-26 | Mercy Bioanalytics, Inc. | Compositions and methods for detection of pancreatic cancer |
WO2023014863A1 (en) | 2021-08-05 | 2023-02-09 | Go Therapeutics, Inc. | Anti-glyco-muc4 antibodies and their uses |
AU2022339819A1 (en) | 2021-09-03 | 2024-04-11 | Go Therapeutics, Inc. | Anti-glyco-lamp1 antibodies and their uses |
AU2022339667A1 (en) | 2021-09-03 | 2024-04-11 | Go Therapeutics, Inc. | Anti-glyco-cmet antibodies and their uses |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5795714A (en) * | 1992-11-06 | 1998-08-18 | Trustees Of Boston University | Method for replicating an array of nucleic acid probes |
CA2118759C (en) | 1993-04-21 | 2004-06-22 | William Jeffrey Allard | Diagnosis and monitoring of lung cancer patients by measurement of nca 50/90 in blood |
US20020025519A1 (en) | 1999-06-17 | 2002-02-28 | David J. Wright | Methods and oligonucleotides for detecting nucleic acid sequence variations |
US7306904B2 (en) | 2000-02-18 | 2007-12-11 | Olink Ab | Methods and kits for proximity probing |
CA2462819A1 (en) | 2001-11-23 | 2003-05-30 | Simon Fredriksson | Method and kit for proximity probing with multivalent proximity probes |
CA2522753C (en) | 2003-04-18 | 2014-06-10 | Becton, Dickinson And Company | Immuno-amplification |
EP1633888B1 (de) * | 2003-06-17 | 2009-03-25 | Keygene N.V. | Mittel und verfahren zum nachweis von zielnukleotidsequenzen unter verwendung von ligationstests mit verbesserten oligonukleotidsondenpaaren |
EP1774035A4 (de) | 2004-06-14 | 2009-02-18 | Univ Leland Stanford Junior | Verfahren und zusammensetzungen zur verwendung zum nachweis von analyten mittels näherungssensoren |
GB0605584D0 (en) | 2006-03-20 | 2006-04-26 | Olink Ab | Method for analyte detection using proximity probes |
WO2007127848A1 (en) | 2006-04-26 | 2007-11-08 | University Of Louisville Research Foundation, Inc | Isolation of membrane vesicles from biological fluids and methods of using same |
CA2705486C (en) | 2007-11-19 | 2019-04-02 | Celera Corporation | Lung cancer markers and uses thereof |
US8481698B2 (en) | 2009-03-19 | 2013-07-09 | The President And Fellows Of Harvard College | Parallel proximity ligation event analysis |
GB201004292D0 (en) | 2010-03-15 | 2010-04-28 | Olink Ab | Assay for localised detection of analytes |
US10669569B2 (en) | 2010-10-15 | 2020-06-02 | Navinci Diagnostics Ab | Dynamic range methods |
US20130295574A1 (en) | 2010-11-10 | 2013-11-07 | Exosome Diagnostics, Inc. | Method for Isolation of Nucleic Acid Containing Particles and Extraction of Nucleic Acids Therefrom |
GB201101621D0 (en) | 2011-01-31 | 2011-03-16 | Olink Ab | Method and product |
WO2012155014A1 (en) | 2011-05-11 | 2012-11-15 | Exosome Diagnostics, Inc. | Nucleic acid extraction from heterogeneous biological materials |
CN106434871B (zh) * | 2011-05-17 | 2020-08-18 | 德克斯特里蒂诊断公司 | 用于检测目标核酸的方法与组合物 |
GB201108678D0 (en) | 2011-05-24 | 2011-07-06 | Olink Ab | Multiplexed proximity ligation assay |
EP2776587A4 (de) | 2011-11-10 | 2015-07-15 | Exosome Diagnostics Inc | Liquor-assay |
US9029086B2 (en) | 2012-01-26 | 2015-05-12 | Masood Kamali Moghaddam | Detection of single and multimodal analytes |
US20150176073A1 (en) | 2012-07-18 | 2015-06-25 | Exosome Diagnostics, Inc. | Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions |
EP2903597B1 (de) | 2012-10-03 | 2019-12-18 | Exosome Diagnostics Inc. | Verwendung von mikrovesikeln bei der diagnose, prognose und behandlung von krankheiten und medizinischen leiden |
US10174366B2 (en) | 2012-11-14 | 2019-01-08 | Olink Bioscience Ab | Localised RCA-based amplification method |
EP2920320B1 (de) | 2012-11-14 | 2016-12-28 | Olink Bioscience AB | Rca-reportersonden und deren verwendung zur detektion von nukleinsäuremolekülen |
US9086412B2 (en) | 2012-12-31 | 2015-07-21 | University Of Louisville Research Foundation, Inc. | Extracellular vesicle-associated protein markers of cancer |
CN105026911B (zh) | 2013-01-03 | 2019-01-22 | 外来体诊断公司 | 用于分离微囊泡的方法 |
CN106029900B (zh) | 2013-08-06 | 2020-02-28 | 外来体诊断公司 | 尿生物标志物群、基因表达特征及其使用方法 |
JP2016533752A (ja) * | 2013-08-28 | 2016-11-04 | カリス ライフ サイエンシズ スウィッツァーランド ホー | オリゴヌクレオチドプローブおよびその使用 |
WO2015047186A1 (en) | 2013-09-30 | 2015-04-02 | Di Wu | Methods to profile molecular complexes by using proximity bar-coding |
GB201401885D0 (en) | 2014-02-04 | 2014-03-19 | Olink Ab | Proximity assay with detection based on hybridisation chain reaction (HCR) |
DK3110977T3 (en) | 2014-02-28 | 2018-07-23 | Exosome Sciences Inc | BRAIN SPECIFIC EXOSOME-BASED DIAGNOSTIC AND EXTRACORPORAL THERAPIES |
CN112239774A (zh) * | 2014-05-15 | 2021-01-19 | 中尺度技术有限责任公司 | 改进的测定方法 |
EP4170044A1 (de) | 2014-06-06 | 2023-04-26 | Cornell University | Verfahren zur identifizierung und zählung von nukleinsäuresequenz-, expressions-, kopie- oder dna-methylierungsänderungen mit kombinierten nuklease-, ligase-, polymerase- und sequenzierungsreaktionen |
WO2015193427A1 (en) | 2014-06-19 | 2015-12-23 | Olink Ab | Determination and analysis of biomarkers in clinical samples |
WO2016093838A1 (en) * | 2014-12-11 | 2016-06-16 | New England Biolabs, Inc. | Enrichment of target sequences |
US11175286B2 (en) * | 2015-01-09 | 2021-11-16 | Spot Biosystems Ltd. | Immunolipoplex nanoparticle biochip containing molecular probes for capture and characterization of extracellular vesicles |
AU2016229076B2 (en) * | 2015-03-09 | 2022-01-20 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
WO2017053516A1 (en) * | 2015-09-22 | 2017-03-30 | Trustees Of Boston University | Multiplexed phenotyping of nanovesicles |
GB201518655D0 (en) | 2015-10-21 | 2015-12-02 | Olink Ab | Method for generating proximity probes |
US10526665B2 (en) | 2016-03-04 | 2020-01-07 | University Of Notre Dame Du Lac | Exosomal biomarkers diagnostic of tuberculosis |
EP4372102A2 (de) | 2016-06-06 | 2024-05-22 | RedVault Biosciences, LP | Zielreporterkonstrukte und verwendungen davon |
CN110446790B (zh) * | 2016-11-30 | 2023-03-31 | 外来体诊断公司 | 使用外来体rna和无细胞dna检测血浆中的突变的方法和组合物 |
WO2018119455A1 (en) | 2016-12-23 | 2018-06-28 | Exosome Diagnostics, Inc. | Biofluid analysis and quantitation systems and methods |
CN111133106A (zh) * | 2017-07-12 | 2020-05-08 | 外来体诊断公司 | 用于分离和富集生物流体来源的细胞外囊泡的方法及其使用方法 |
US11345957B2 (en) | 2017-07-18 | 2022-05-31 | Exosome Diagnostics, Inc. | Methods of treating glioblastoma in a subject informed by exosomal RNA signatures |
WO2019022542A2 (ko) | 2017-07-26 | 2019-01-31 | ㈜로제타엑소좀 | 양이온을 이용한 세포밖 소포체의 분리 방법 |
EP3660142A4 (de) | 2017-07-26 | 2021-05-05 | Rosetta Exosome | Verfahren zur isolierung von extrazellulären vesikeln unter verwendung von kationen |
WO2019066501A1 (ko) | 2017-09-27 | 2019-04-04 | ㈜로제타엑소좀 | 크기 배제 크로마토그래피를 이용한 세포밖 소포체의 분석 방법 및 이의 용도 |
WO2019103548A2 (ko) | 2017-11-24 | 2019-05-31 | ㈜로제타엑소좀 | 반건식 크기 배제 크로마토그래피를 이용한 세포밖 소포체의 분리 방법 |
EP3793715A2 (de) * | 2018-05-17 | 2021-03-24 | Meso Scale Technologies, LLC | Verfahren zur isolierung von oberflächenmarkerindikatoren |
WO2019236853A1 (en) | 2018-06-06 | 2019-12-12 | Exosome Diagnostics, Inc. | Methods for developing urine biomarkers and for detecting bladder cancer |
US20210255189A1 (en) | 2018-06-15 | 2021-08-19 | Olink Proteomics Ab | Biomarker panel for ovarian cancer |
US20210382043A1 (en) * | 2018-10-23 | 2021-12-09 | Meso Scale Technologies, Llc. | Methods for isolating surface marker displaying agents |
WO2020106853A1 (en) | 2018-11-20 | 2020-05-28 | Exosome Diagnostics, Inc. | Compositions and methods for internal controls of microvesicle isolations |
CN113748217B (zh) | 2019-03-01 | 2023-08-25 | 仁慈生物分析公司 | 用于靶实体检测的系统、组合物和方法 |
KR20220129591A (ko) * | 2020-01-17 | 2022-09-23 | 메르시 바이오애널리틱스, 인코포레이티드 | 난소암의 검출을 위한 조성물 및 방법 |
-
2020
- 2020-02-28 CN CN202080017641.1A patent/CN113748217B/zh active Active
- 2020-02-28 AU AU2020233286A patent/AU2020233286B2/en active Active
- 2020-02-28 US US16/805,637 patent/US11085089B2/en active Active
- 2020-02-28 US US17/435,697 patent/US20220155304A1/en active Pending
- 2020-02-28 WO PCT/US2020/020529 patent/WO2020180741A1/en unknown
- 2020-02-28 KR KR1020217031580A patent/KR102599718B1/ko active IP Right Grant
- 2020-02-28 SG SG11202109423TA patent/SG11202109423TA/en unknown
- 2020-02-28 EP EP21201011.0A patent/EP3998349A3/de active Pending
- 2020-02-28 EP EP20766432.7A patent/EP3931351A4/de active Pending
- 2020-02-28 JP JP2021549902A patent/JP7344973B2/ja active Active
- 2020-02-28 CA CA3129868A patent/CA3129868A1/en active Pending
-
2021
- 2021-03-17 US US17/204,773 patent/US20210214806A1/en active Pending
-
2022
- 2022-10-03 AU AU2022241629A patent/AU2022241629A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2022241629A1 (en) | 2022-10-27 |
US11085089B2 (en) | 2021-08-10 |
US20210214806A1 (en) | 2021-07-15 |
AU2020233286A1 (en) | 2021-10-14 |
WO2020180741A1 (en) | 2020-09-10 |
EP3931351A1 (de) | 2022-01-05 |
AU2020233286B2 (en) | 2022-10-20 |
CN113748217B (zh) | 2023-08-25 |
CA3129868A1 (en) | 2020-09-10 |
US20200299780A1 (en) | 2020-09-24 |
CN113748217A (zh) | 2021-12-03 |
US20220155304A1 (en) | 2022-05-19 |
KR102599718B1 (ko) | 2023-11-09 |
JP7344973B2 (ja) | 2023-09-14 |
JP2022521781A (ja) | 2022-04-12 |
EP3998349A2 (de) | 2022-05-18 |
KR20210141952A (ko) | 2021-11-23 |
EP3931351A4 (de) | 2022-05-11 |
EP3998349A3 (de) | 2022-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202109423TA (en) | Systems, compositions, and methods for target entity detection | |
EP3797314A4 (de) | Systeme und verfahren zur verbesserten zielerkennung | |
EP3683719A4 (de) | Verfahren, vorrichtung und system zur zieldetektion | |
EP3794368A4 (de) | Systeme und verfahren zur detektion von objekten | |
EP3625547A4 (de) | Vorrichtungen, systeme und verfahren zur agrochemischen detektion und agrochemische zusammensetzungen | |
EP3494448A4 (de) | Systeme und verfahren zur trajektoriebestimmung | |
EP3692338A4 (de) | Systeme und verfahren zur wegbestimmung | |
EP3532902A4 (de) | Systeme und verfahren zur wegbestimmung | |
EP3345117A4 (de) | Systeme und verfahren zur erkennung und vermeidung von spoofing | |
EP3884411A4 (de) | Systeme und verfahren zur erkennung von malware und ransomware auf der basis von kryptowährung | |
EP3336804A4 (de) | Verfahren und system zur erkennung eines beweglichen ziels | |
EP3420083A4 (de) | Verfahren und zusammensetzungen zur zielerkennung | |
EP3270585A4 (de) | Zielverfolgungsverfahren, vorrichtung und system | |
EP3676803A4 (de) | Ziel, verfahren und system zur kamerakalibrierung | |
EP3285635A4 (de) | Systeme und verfahren zur bestimmung einer distanz von einem objekt | |
EP3759240A4 (de) | Systeme und verfahren zur unterscheidung von effekten bei zielen | |
EP3915243A4 (de) | Verfahren und systeme zur erkennung eines scoreboardbereichs | |
GB202204573D0 (en) | Methods, compositions, and systems for profiling or predicting an immune response | |
IL287027A (en) | Methods and systems for high performance and versatile molecular imaging | |
KR101980653B9 (ko) | 표적 탐지 및 추적 방법 | |
EP3717871A4 (de) | Systeme und verfahren zur wegbestimmung | |
EP3884065A4 (de) | Direct-to-library-methoden, systeme und zusammensetzungen | |
EP3687405A4 (de) | System und verfahren zur ortung einer zielperson | |
EP3417278A4 (de) | Verfahren, systeme und zusammensetzungen für den nachweis von aldehyden | |
EP3805784A4 (de) | Zieldetektionsverfahren, system und computerlesbares speichermedium |